{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:01:05Z","timestamp":1774645265112,"version":"3.50.1"},"reference-count":23,"publisher":"Japan Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1507\/endocrj.ej15-0057","type":"journal-article","created":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T18:01:48Z","timestamp":1431021708000},"page":"627-632","source":"Crossref","is-referenced-by-count":16,"title":["Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel &lt;i&gt;CDC73&lt;\/i&gt; mutation"],"prefix":"10.1507","volume":"62","author":[{"given":"Yusuke","family":"Shibata","sequence":"first","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Shinshu University School of Medicine, Matsumoto, 390-8621, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Shinshu University School of Medicine, Matsumoto, 390-8621, Japan"},{"name":"Department of Drug Discovery Science, Shinshu University School of Medicine, Matsumoto, 390-8621, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Takei","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Shinshu University School of Medicine, Matsumoto, 390-8621, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Uchino","sequence":"additional","affiliation":[{"name":"Department of Surgery, Noguchi Thyroid Clinic and Hospital Foundation, Beppu, 874-0902, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Department of Genetic Medicine, Sapporo Medical University, Sapporo, 060-8556, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhisa","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Shinshu University School of Medicine, Matsumoto, 390-8621, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","unstructured":"1. Potts J, J&uuml;ppner H (2011) Disorders of the parathyroid gland and calcium homeostasis. In: Longo D, Fauci A, Kasper D, Hauser S, Jameson J, Loscalzo J eds. Harrison&rsquo;s Principles of Internal Medicine, 18th Edition. Mcgraw-hill, New York, USA: 3096-3119."},{"key":"2","unstructured":"2. Han D, Trooskin S, Wang X (2012) Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism. <i>J Endocrinol Invest<\/i> 35: 548-552."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Amstrup AK, Rejnmark L, Mosekilde L (2011) Patients with surgically cured primary hyperparathyroidism have a reduced quality of life compared with population-based healthy sex-, age-, and season-matched controls. <i>Eur J Endocrinol<\/i> 165: 753-760.","DOI":"10.1530\/EJE-11-0301"},{"key":"4","unstructured":"4. Bradley KJ, Thakker RV (2006) The hyperparathyroidism-jaw tumour (HPT-JT) syndrome. <i>Clin Cases Miner Bone Metab<\/i> 3: 167-174."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Chen JD, Morrison C, Zhang C, Kahnoski K, Carpten JD, et al. (2003) Hyperparathyroidism-jaw tumour syndrome. <i>J Intern Med<\/i> 253: 634-642.","DOI":"10.1046\/j.1365-2796.2003.01168.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bradley KJ, Hobbs MR, Buley ID, Carpten JD, Cavaco BM, et al. (2005) Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome. <i>J Intern Med<\/i> 257: 18-26.","DOI":"10.1111\/j.1365-2796.2004.01421.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, et al. (2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. <i>Nat Genet<\/i> 32: 676-680.","DOI":"10.1038\/ng1048"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lin L, Zhang JH, Panicker LM, Simonds WF (2008) The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene. <i>Proc Natl Acad Sci U S A<\/i> 105: 17420-17425.","DOI":"10.1073\/pnas.0710725105"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Woodard GE, Lin L, Zhang JH, Agarwal SK, Marx SJ, et al. (2005) Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1\/PRAD1 expression. <i>Oncogene<\/i> 24: 1272-1276.","DOI":"10.1038\/sj.onc.1208274"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Schulte KM, Talat N (2012) Diagnosis and management of parathyroid cancer. <i>Nat Rev Endocrinol<\/i> 8: 612-622.","DOI":"10.1038\/nrendo.2012.102"},{"key":"11","unstructured":"11. Rich TA, Hu MI, Martin JW, Perrier ND, Waguespack SG (1993) CDC73-Related Disorders. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K eds. <i>GeneReviews<\/i>, Seattle, USA (online)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Starker LF, Akerstrom T, Long WD, Delgado-Verdugo A, Donovan P, et al. (2012) Frequent germ-line mutations of the MEN1, CASR, and HRPT2\/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism. <i>Horm Cancer<\/i> 3: 44-51.","DOI":"10.1007\/s12672-011-0100-8"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ullmann U, Unuane D, Velkeniers B, Lissens W, Wuyts W, et al. (2013) A new double substitution mutation in the <i>MEN1<\/i> gene: a limited penetrance and a specific phenotype. <i>Eur J Hum Genet<\/i> 21: 695-697.","DOI":"10.1038\/ejhg.2012.241"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Filopanti M, Verga U, Ermetici F, Olgiati L, Eller-Vainicher C, et al. (2012) MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly. <i>Eur J Endocrinol<\/i> 167: 157-164.","DOI":"10.1530\/EJE-12-0117"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Nagamura Y, Yamazaki M, Shimizu S, Sano K, Tsukada T, et al. (2012) A novel splice site mutation of the <i>MEN1<\/i> gene identified in a patient with primary hyperparathyrodism. <i>Endocr J<\/i> 59: 523-530.","DOI":"10.1507\/endocrj.EJ12-0037"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Furtado S, Ghosal N, Furtado SV, Gupta K, Heqde AS (2012) Neurocutaneous spectrum of multiple endocrine neoplasia-1. <i>Indian J Dermatol Venereol Leprol<\/i> 78: 93-96.","DOI":"10.4103\/0378-6323.90956"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Bricaire L, Odou MF, Cardot-Bauters C, Delemer B, North MO, et al. (2013) Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism. <i>J Clin Endocrinol Metab<\/i> 98: E403-408.","DOI":"10.1210\/jc.2012-2789"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Frank-Raue K, Haag C, Schulze E, Keuser R, Raue F, et al. (2011) <i>CDC73<\/i>-related hereditary hyperparathyroidism: five new mutations and the clinical spectrum. <i>Eur J Endocrinol <\/i>165: 477-483.","DOI":"10.1530\/EJE-11-0003"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Cavaco BM, Santos R, Felix A, Carvalho D, Lopes JM, et al. (2011) Identification of<i> De Novo<\/i> germline mutations in the <i>HRPT2<\/i> gene in two apparently sporadic cases with challenging parathyroid tumor diagnoses. <i>Endocr Pathol<\/i> 22: 44-52.","DOI":"10.1007\/s12022-011-9151-1"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Dominques R, Tomaz RA, Martins C, Nunes C, Buqalho MJ, et al. (2012) Identification of the first germline<i> HRPT2<\/i> whole-gene deletion in a patient with primary hyperparathyroidism. <i>Clin Endocrinol (Oxf)<\/i> 76: 33-38.","DOI":"10.1111\/j.1365-2265.2011.04184.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Newey PJ, Bowl MR, Cranston T, Thakker RV (2010) Cell division cycle protein 73 homolog (<i>CDC73<\/i>) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors. <i>Hum Mutat<\/i> 31: 295-307.","DOI":"10.1002\/humu.21188"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Haven CJ, Wong FK, van Dam EW, van der Juijt R, van Asperen C, et al. (2000) A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome. <i>J Clin Endocrinol Metab<\/i> 85: 1449-1454.","DOI":"10.1210\/jc.85.4.1449"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Iacobone M, Masi G, Barzon L, Porzionato A, Macchi V, et al. (2009) Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred. <i>Langenbecks Arch Surg<\/i> 394: 817-825.","DOI":"10.1007\/s00423-009-0511-y"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/62\/7\/62_EJ15-0057\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T07:09:37Z","timestamp":1498201777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/62\/7\/62_EJ15-0057\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej15-0057","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}